Showing results (171-180 of 409) with videos related to

Sort By:
Pageof 41
Plos One|November 5, 2014
Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascitesMattias Mandorfer, Simona Bota, Philipp Schwabl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2018
Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment-A multicenter retrospective studyGiovanna Ferraioli, Annalisa De Silvestri, Thomas Reiberger, et al.
Digestive Diseases and Sciences|June 19, 2019
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal HypertensionGeorg Semmler, Judith Stift, Bernhard Scheiner, et al.
Gastroenterology|March 18, 2014
Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitisMattias Mandorfer, Simona Bota, Philipp Schwabl, et al.
AIDS (London, England)|January 14, 2016
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver diseaseMattias Mandorfer, Philipp Schwabl, Sebastian Steiner, et al.
Wiener Klinische Wochenschrift|January 9, 2020
Portal hypertensive gastropathy is associated with iron deficiency anemiaBenedikt Simbrunner, Andrea Beer, Katharina Wöran, et al.
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
Journal of Hepatology|November 26, 2025
A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis CJosep M Llibre, Christoph Boesecke, Juhi Moon, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2023
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppressionMathias Jachs, Marlene Panzer, Lukas Hartl, et al.
Pageof 41